Evofem’s mission is to empower women by providing products that give women the control and flexibility they desire
Evofem Biosciences, Inc. has raised $5.6M in total funding. The most recent round was Series B.
Evofem Biosciences, Inc. is headquartered in San Diego, CA.
Evofem’s mission is to empower women by providing products that give women the control and flexibility they desire
Founded in 2007, this San Diego company has been publicly traded since 2018 (formerly Nasdaq, now OTC: EVFM) under CEO Saundra Pelletier, developing the hormone-free contraceptive Phexxi.
Free to use in articles, research, and reference works. Stable URL, will not change. Data on this page last updated August 26, 2026.